|
Ronald C. Renaud has served as the chief financial officer of Idenix Pharmaceuticals Inc. since June 2007. He is responsible for all finance treasury and investor relations functions. Mr. Renaud brings a unique mix of skills to this role with his finance experience at public biotechnology companies and on Wall Street as well as his science background. Prior to joining Idenix Mr. Renaud served as chief financial officer of Keryx Biopharmaceuticals. In this role he was responsible for the strategic planning and development of the finance function to support the company’s growth and its late-stage product candidate development. Prior to his position at Keryx he spent several years as a senior biotechnology equity analyst for leading investment banks including Bear Stearns Schwab SoundView and JP Morgan. Additional industry experience includes Mr. Renaud's more than five years at Amgen Inc. where he held positions in clinical research investor relations and finance.
Mr. Renaud holds a Masters in Business Administration from the Marshall School of Business at the University of Southern California and a Bachelor of Arts from St. Anselm College in Manchester NH. | 